- Home
- QIPT
as 12-20-2024 3:41pm EST
Stocks
Quipt Home Medical Corp provides in-home monitoring equipment, supplies, and services to patients. The company's services consist of Daily and Ambulatory Aides, Power Mobility, INR Self-Testing, Respiratory Equipment Rental, Home ventilation, Oxygen Therapy, and Sleep Apnea and PAP Treatment.
| Founded: | 1993 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | 103.8M | IPO Year: | N/A |
| Target Price: | $7.67 | AVG Volume (30 days): | 203.1K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.16 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.30 - $5.29 | Next Earning Date: | 12-16-2024 |
| Revenue: | $245,915,000 | Revenue Growth: | 16.17% |
| Revenue Growth (this year): | 11.15% | Revenue Growth (next year): | 4.68% |
Latest Quipt Home Medical Corp. News
QIPT Breaking Stock News: Dive into QIPT Ticker-Specific Updates for Smart Investing
GuruFocus.com
4 days ago
Quipt Home Medical Corp (QIPT) Q4 2024 Earnings Call Highlights: Record Revenue Amidst Industry ...
Simply Wall St.
4 days ago
Quipt Home Medical Full Year 2024 Earnings: Misses Expectations
GlobeNewswire
6 days ago
Quipt Home Medical Reports Fourth Quarter and Fiscal Year 2024 Financial Results
GuruFocus.com
6 days ago
What To Expect From Quipt Home Medical Corp (TSX:QIPT) Q4 2024 Earnings
GuruFocus.com
9 days ago
What To Expect From Quipt Home Medical Corp (TSX:QIPT) Q4 2024 Earnings
GlobeNewswire
18 days ago
Quipt Home Medical Corp. to Announce Fiscal Fourth Quarter and Full Year 2024 Financial Results on December 16, 2024
Simply Wall St.
25 days ago
3 TSX Penny Stocks With Market Caps Over CA$20M To Watch
Simply Wall St.
2 months ago
Alithya Group And 2 Other TSX Penny Stocks To Consider
Compare QIPT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "QIPT Quipt Home Medical Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.